Shares of HIMS experienced a dramatic slump today following the unexpected termination of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by over fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts speculate that it